The experiments involving TRPV2 heterozygotes indicate, however, that downregulation of TRPV2 expression to levels similar to those seen in diabetes is adequate to explain the loss of the myogenic response and pressure autoregulation in the retina. Here, TRPV2 is linked to diabetes mellitus.